MedTech Syndicates is a funding concept that connects clinicians with MedTech innovations seeking early-stage investment and support. It offers a platform for clinicians to invest in areas where they have medical expertise and provides services for MedTech start-ups.

MedTech Syndicates

MedTech Syndicates | 1,814 followers on LinkedIn. Clinician Lead Investment Syndication | &quot;MedTech Syndicates&quot; (MTS) is a closed members only site designed to form syndicates exclusively for clinicians that allows for the review, evaluation and investment in early start stage MedTech companies in a clinical area that they have expert knowledge or in other clinical areas with the knowledge of other members who endorse the product/service.

President and CEO, Society of Physician Entrepreneurs, another lousy golfer, terrible cook, friction fixer

Arlen Meyers, MD, MBA

Urologist at University Health Network

Dean Elterman, MD, MSc, FRCSC

Interviewing illumicell AI 's co-founders Jeyla Sadikova and Michel Bielecki MD MPH was great fun. I will be sharing more later but this is one part of the interview that I really enjoyed. Hearing about how Jeyla was invited to Necker Island to meet Richard Branson and his time. If you are interested in learning more about the Founders and illumicell AI we are going LIVE to night to discuss the company, the tech and the goals. Tonight @ 21.00 ET https://lnkd.in/gfsU8-UE

Titin KM is a company that looks at Shoulder rehab and other joints in a very unique way. Unhappy with the status quo of dumb-bells, bands and other non metric based treatments CEO and founder Kole Mickolio DO, MSc. decided to revolutionize the therapy. With this the last round for angel investors it is a great time to look to how clinicians can support this amazing technology! This week we will be hosting a webinar on Titan KM Date: 19th November Time: 22:00 ET https://lnkd.in/emv3-upa

illumicell AI is a company led by Michel Bielecki MD MPH and Jeyla Sadikova who we are hosting a webinar for this week. This technology addresses a genuine unmet clinical need. This week I spoke to a number of fertility specialists who welcome this technology to the space. If you are interested in fertility and how Illumicell AI are looking to change fertility diagnostics... take a look at this brief video and then sign up for the webinar where YOU can ask the questions and get the answers directly. Date: 18th November 2024 Time: 21:00 ET https://lnkd.in/gfsU8-UE

𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐰𝐞𝐛𝐢𝐧𝐚𝐫: Learn about new MedTech through membership of MedTech Syndicates. UnderControl, utilizes an implantable neuromodulation system to treat Underactive Bladder (UAB). UAB is a chronic condition affecting over 20 million patients in the US alone who have damage to the nerves responsible for initiating a void. These patients have no pharmaceutical options and must rely on 4-6 daily self-catheterizations to empty their bladder. UnderControlTM provides UAB patients with on-demand bladder voiding by delivering 60 seconds of stimulation to replace self-catheterization.

Tonight we are talking to PAXOS Medical Live. Here is a little teaser about the animal trials that they have done to date and their background in Neuromodulation. Don't forget, if you are interested in hearing more, the details of the webinar are below: If you are interested in hearing more from them. Please register for their Webinar: Date: Thursday 14th November 2024 Time: 21:00pm ET Link: https://lnkd.in/eRk3yZ2H Jeff Erb Matthew O. Fraser, PhD Dean Elterman, MD, MSc, FRCSC

A smart therapeutics platform designed for prevention, targeted recovery, and sports medicine performance enhancement through objective metrics and data driven decision making. Significant Milestones: - Successful design, development, and production of a novel MVP industry disrupting technology in the Humero Tech C1. - Successful use of investor funds to vertically integrate and implement R&D, production, QMS, regulatory, sales, IT, customer service, engineering, and leadership teams into a foundational high level MVP level workforce. - Titin has assembled high level consultants and relationships within the academic medical, private practice medical and therapeutics sectors, MLB, NFL, NCAA, and beyond working together to bring our technologies to various markets. - Titin has begun the launch process by placing units for data gathering in the field within the MLB as well as sales negotiations in various sectors. All luminary sites are accounted for across all major industries. - Titin has garnered significant market interest already outpacing production capabilities, fast tracking our scaling process. There is already a significant demand for our future technologies (IP filed). Voice of customer pilot studies have provided real world evidence of the quality of our products. - U of Utah, Emory, and Mayo clinic are all actively involved in assisting Titin with research and knowledge advancement in the field of Orthopedics and Sports Medicine. - Titin has private research entities within the MLB and beyond assisting in data acquisition processes. - Titin has designed and developed our smart capabilities to seamlessly transition into AI. Titin with its novel unit for quantifying dynamic strength and beyond will hold one of the marquis datasets amongst a large demographic to advance the field of therapeutics, preventative medicine, recovery, and performance to new heights. - Titin has begun removing barriers to patient follow up and collaboration between Medical, PT, and beyond. Contact and collaboration amongst large medical device manufacturers and Titin in regards to future relationships and strategic partnerships. Invitation to occupy and establish our first “smart therapeutics center” in collaboration with the University of Utah Orthopedic Center.

illumicell AI (Techstars'23) is one of those companies that when you talk to the founders Michel Bielecki MD MPH and Jeyla Sadikova you really get a feeling that execution is what they do best! Looking at a new generation of fertility diagnostics, illumicell Ai could revolutionise an industry that is seeing demand outstrip supply. I caught up with them this week to ask them some questions about their background and also the technology. If you are interested in this field... check out our upcoming Webinar! Webinar Details: Date: Mon, November 18th, 2024, Time: 21:00 AM ET Link: https://lnkd.in/gfsU8-UE

This week Gavin sat down and interviewed the team at Paxos Medical, Jeff Erb and Matthew O. Fraser, PhD . Listen to them discuss how they came to look at the underactive bladder market. If you are interested in hearing more from them. Please register for their Webinar: Date: Thursday 14th November 2024 Time: 21:00pm ET Link: https://lnkd.in/eRk3yZ2H

illumicell AI is a fertility tech company that is coupling patented AI algorithms with our proprietary visualization system to decentralize fertility diagnostics, driving enhanced operational efficiency and faster time to revenue for clinics, and improved patient outcomes. HIGHLIGHTS & MILESTONES - Raised $1.2M in Pre-Seed; lead – Brent Ahrens, GP at Canaan - Developed a Proof-Of-Concept prototype - Filed a provisional patent for the system and its future applications - Signed 25+ LOIs in USA, Switzerland, and Japan, with the leading fertility experts and urologists from Boston IVF, Harvard Chan and Stanford Medicine among others - Obtained promising preclinical data showcasing its accuracy in quantifying key male fertility parameters - Kicked off clinical trials at Fertas SA in Switzerland RECOGNITION - Harvard Innovation Labs - MassChallenge Boston - Techstars (DeepTech) - Creative Destruction Lab (AI stream) - Keihanna Science City: KGAP+ (connecting international startups with Japanese partners) - TechCrunch Disrupt Top 200 (2023) - Global Excellence Award: Fertility Technology Innovators of the Year 2024 - New England - Slush Top 100 (2024) - Harvard Pagliuca Lab members

In a world where MedTech startups face fierce competition, understanding the full spectrum of value is essential. Craig Solid, CEO of Solid Research Group, LLC explains why price isn’t everything—it’s about the broader impact on efficiency, risk, and system integration. 📊 Watch the video for insights on how to support your innovation with solid economic analysis. Visit our website to explore how we can support your MedTech journey 👉 https://lnkd.in/giYKdgb9 #MedTech #HealthEconomics #ThoughtLeadership #Innovation #Healthcare

news impact assignment basic	general
public peers	general	Nov 18, 2024 2:47 PM	dacc2530
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 18, 2024 2:47 PM	3fc10070
crunchbase trigger	general	Nov 18, 2024 2:47 PM	437a1db6
crunchbase profile	general	Nov 19, 2024 3:47 AM	18e1da02
li profile	general	Nov 18, 2024 2:47 PM	d6ce1034
translate crunchbase fundingrounds	general
peers	general	Nov 18, 2024 2:47 PM	8459002d
news basic	general	Nov 18, 2024 2:47 PM	d1122d99
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:MEDTECHSYNDICATES

MedTech Syndicates